Global Pharma Supply Chain Study 2024

The Global Pharma Supply Chain Study 2024 is a comprehensive report that analyzes current developments in pharmaceutical supply chains and logistics. It outlines the main challenges faced by the industry, including the need for supply chain optimization and visibility, particularly in the wake of post-pandemic disruptions. The study emphasizes the importance of collaborative forecasting and the use of AI-based tools to enhance supply chain resilience. It also discusses the trends towards automation and the necessity of integrating control towers for real-time visibility. The report is based on a survey conducted with over 300 participants globally, reflecting diverse perspectives from the Pharma and Life Sciences sectors. It identifies key areas for improvement and highlights the ongoing need for adaptation in the industry to meet evolving demands and challenges. The findings aim to guide stakeholders in implementing effective strategies for optimizing their supply chain networks.